References
- Beer M, Sandstede J, Landschutz W, et al. Altered energy metabolism after myocardial infarction assessed by 31P-MR-spectroscopy in humans. Eur Radiol 2000; 10:1323–8.
- Blamire AM, Rajagopalan B, Radda GK. Measurement of myocardial pH by saturation transfer in man. Magn Reson Med 1999;41:198–203.
- Bottomley PA. MR spectroscopy of the human heart: the status and the challenges. Radiology 1994;191: 593–612.
- Buchthal SD, den Hollander JA, Merz CN, et al. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med 2001;342: 829–35.
- Chida K, Saito H, Nagasaka T, et al. Feasibility of rapid-sequence 31P-MRS of the human heart using a 1.5-Tesla (T) clinical imager. Radiology 2002;Suppl 225:702.
- Conway A, Bottomley PA, Ouwerkerk R, et al. Mitral regurgitation impaired systolic function, eccentric hypertrophy, and increased severity are linked to lower phosphocreatine/ATP ratios in humans. Circulation 1998;97:1716–23.
- Hetherington HP, Luney DJ, Vaughan JT, et al. 3D 31P spectroscopic imaging of the human heart at 4.1 T. Magn Reson Med 1995;33:427–31.
- Henriksen O. MR spectroscopy in clinical research. Acta Radiol 1994;35:96–116.
- Jung W-I, Sielerding L, Breuer J, et al. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 1998;97: 2536–42.
- Kallil-Filho R, Albuquerque CP, Weiss RG, et al. Normal high energy phosphate ratios in 'Stunned' human myocardium. J Am Coll Cardiol 1997;30: 1228–32.
- Neubauer S, Horn M, Cramer M, et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997;96:2190–6.
- Neubauer S, Horn M, Pabst T, et al. Cardiac high-energy metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy. J Investig Med 1997;45:453–62.
- Pohmann R, von Kienlin M, Haase A. Theoretical evaluation and comparison of fast chemical shift imaging methods. J Magn Reson 1997;129:145–60.
- von Kienlin M, Beer M, Greiser A, et al. Advances in human cardiac 31P-MR spectroscopy: SLOOP and clinical applications. J Magn Reson Imag 2001;13:521–7.
- Weiss RG, Kallil-Filho R, Bottomley PA. Clinical cardiac magnetic spectroscopy. In: Manning WJ, Pennell DJ, editors. Cardiovascular magnetic resonance. New York: Churchill Livingstone; 2002. p. 437–46.